Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$38,460,473
-$4,816,559 QoQ
Shares Held
451,467
-31.2% QoQ
Ownership
0.325%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#65
of 477 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. CYTK ranks #26 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in CYTK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,460,473 | 451,467 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $43,277,032 | 656,608 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $21,414,949 | 337,031 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $9,836,740 | 178,980 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $701,273 | 21,225 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $81,537,149 | 2,028,792 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $101,291,842 | 2,153,313 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $98,931,412 | 1,873,701 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $90,922,654 | 1,678,159 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $179,257,457 | 2,556,803 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $52,272,003 | 626,087 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $45,190,726 | 1,533,969 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $8,330,887 | 255,392 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $26,227,353 | 745,307 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $46,345,188 | 1,011,462 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $46,312,676 | 955,886 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $53,164,752 | 1,353,137 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $1,137,613 | 30,905 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $2,013,314 | 44,171 | Shares | Other | 2022-02-14 | |
| 2021-06-30 | $2,622,115 | 132,497 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,371,052 | 273,906 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $1,086,336 | 52,278 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,491,357 | 207,453 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||